466 submissions from 435 organizations told the European Commission what they think about this file. Here is what each of them said, in their own words.
The Commission received 677 submissions on this file. Shown here: the 466 from organizations. Not shown: 207 from private individuals. Their submissions are personal data; the Commission publishes them under its own legal basis, and republishing them by name here would need one we do not have. Organizations act in a public capacity, so their positions are public record. Also not shown: 4 further submissions we do not publish for other reasons: no quotable text (a comment under 250 characters and no readable paper), no organization named, or a private person who filed under their own name. About this data →
Who showed up
80 submissions from industry (companies and their trade associations) against 213 from civil society: NGOs, consumer organizations, environmental groups and trade unions.
Industry 80Civil society 213Public authorities, academia, other 170
Groupings use the respondent type each organization selected when filing. Counting submissions, not organizations: a body that filed twice is counted twice. An identical text filed by several organizations counts once: 3 submissions here repeat 2 texts word for word and are folded into them.
What the room declares
127 of 435
in the EU Register
397
full-time lobbying staff
€43.2M+
declared costs a year
301
EP accreditations declared
Self-declared to the EU Transparency Register (snapshot 27 Oct 2026). The cost figure sums band floors, so the true total is higher.
The file, right now
No consultation closing date is recorded for this file.
Policy area
Health & food (DG SANTE)
Where it stands
Awaiting adoption
Commission reference
COM(2025)1024
How it got here
Call for evidence17 Sept 2025
Also on the Commission’s pipeline for this file, with no date recorded: Initiative planned, Communication.
The European Commission's call for evidence on the future EU Plan for Cardiovascular Health is welcomed, in the hope that it may represent an opportunity to improve access to care, early diagnosis of cardiovascular diseases, and to further strengthen prevention programs at all levels and in all Member States. Cardiovascular diseases are the leading cause of mortality and morbidity worldwide.
Merck has a long history and extensive experience in the management of cardiovascular diseases through our established portfolio of medicines and patient support through integrated care solutions. As a key player in the pharma industry, we recognize the urgent need for a comprehensive EU Cardiovascular Health Plan that addresses the growing burden of cardiovascular diseases (CVDs) across Europe.
As part of Inserm (National Institute of Health and Medical Research), the only French public research organization entirely dedicated to human health, we strongly encourage that the following biomedical research areas need to be addressed to reduce the burden of cardiovascular diseases : Area 1 Innovative therapies for cardiovascular diseases: This research area aims at identifying clinically useful molecular and…
Cardiovascular disease remains the leading cause of death and disability in Europe, placing enormous strain on individuals, families and health systems. Nutrition is one of the most important drivers of cardiovascular risk, yet many Europeans face food environments that make healthy choices difficult.
European Commission’s call for evidence on an EU Cardiovascular Health Plan Comment from the Institute for Quality and Efficiency in Health Care (IQWiG) 12 September 2025 The Institute for Quality and Efficiency in Health Care (IQWiG) is Germany’s independent agency for health technology assessment (HTA, https://www.iqwig.de/en/).
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
Familial hypercholesterolaemia (FH) and elevated lipoprotein(a) [Lp(a)] are the most common, inherited lipid conditions in Europe. They are major drivers of premature heart attacks, strokes and other cardiovascular diseases, yet remain largely invisible to citizens and in public health strategies. Around one in 300 people live with FH and one in five with high Lp(a).
The proposal for a European Plan for Cardiovascular Health represents an opportunity to reduce the impact of cardiovascular diseases (CVDs) on the population and healthcare systems. This initiative should primarily focus on improving access to prevention services, early diagnosis, patient management, and treatment, while promoting equity among Member States.
The Novartis Foundation welcomes the European Unions plan to improve health of millions of citizens by establishing a comprehensive cardiovascular health plan to address Europes leading cause of death. Appropriate management of cardiovascular disease is a domain with abundant contradictions.
To tackle the challenges facing EU health systems and strengthen the competitiveness and capabilities of the health industry, the EU Cardiovascular Health Plan should incorporate regulatory tools that actively foster innovation.
The International Pharmaceutical Federation (FIP), the global organisation representing pharmacists, pharmaceutical educators and pharmaceutical scientists in over 150 countries, welcomes the European Commissions initiative to develop a comprehensive EU Cardiovascular Health (CVH) Plan.
The Belgian Alliance for Cardiovascular Health (BACH) welcomes the call for evidence for a comprehensive EU Cardiovascular Health (CVH) Plan. As a multi-stakeholder alliance, BACH is committed to contributing its expertise and insights to this crucial initiative. Cardiovascular diseases (CVD) remain the leading cause of death in the EU, claiming 1.7 million lives each year and costing the economy around 280 billion.
In response to the upcoming EU plan for cardiovascular health (CVH), the Alliance for Workplace Awareness and Response to Emergencies (AWARE) urges EU decision-makers to prioritise the promotion of cardiovascular health and safety in the workplace. In preventing and mitigating cardiovascular risks at work, the CVH Plan can secure resilient initiatives for heart health.
The Institute for Rational Addiction Policies (IRAP) welcomes the European Commissions upcoming EU Cardiovascular Health Plan but strongly opposes reliance on ineffective prohibitionist approaches that have historically failed to address addictions and related health risks.
In my position of a chair of a large patients organization of people living with diabetes, I consider of huge importance that health institutions in Europe make all efforts and necessary moves to diminish the significant burden of cardiovascular disease. Moreover, CVD is the most common late complications condition for people with diabetes and very often the cause of prematured deaths.
APDP Diabetes Portugal supports the position of the International Diabetes Federation Europe (IDFE), an umbrella organisation of 73 national diabetes associations across 26 EU countries, representing both people living with diabetes (PwD) and healthcare professionals (HCPs). We welcome the European Commissions commitment to tackling the burden of cardiovascular disease (CVD).
The forthcoming European Union Cardiovascular Health Plan provides an important opportunity to tackle the burden of Europes leading cause of death, cardiovascular disease (CVD), and to help patients in need of access to care. A key form of CVD is Structural Heart Disease (SHD), a life-threatening and seriously debilitating condition, which can affect the hearts valves, walls, and muscles.
The European Society of Hypertension (ESH) welcomes the EU NCD Initiative Healthier Together and the actions on cardiovascular disease and diabetes. We would like to call upon Member States and the European Commission to use this important initiative to take appropriate action to address the growing burden of hypertension as an unmet medical need and key risk factor for cardiovascular disease as well as…
On the EU level, the most important fields of action to protect cardiovascular health are promoting healthy food (1) and improve air quality (2). 1) In 2019, 1.55 million people in the WHO European Region died from Cardiovascular Diseases attributable to suboptimal diets (red meat, processed foods, high in sugar, salt and saturated fatty acids).
The Brewers of Europe appreciates the opportunity to provide evidence and welcomes the initiative to strengthen cardiovascular health and support an evidence-based, balanced approach that improves outcomes for all citizens. In relation to alcohol, we recommend: Any alcohol-related objectives should focus on promoting responsible consumption and tackling harmful use, in line with the WHO Global Alcohol Action Plan.
Vin & Société represents the 440 000 players in vines and wine in France. For many years, our organisation has been proactive in preventing and promoting responsible consumption. Our actions aim to prevent risky behaviour, protect vulnerable audiences (pregnant women, minors, drivers) and promote moderation as the central value of wine consumption.
Filed in French · English published by the European Commission
Input to the European Commissions initiative EU cardiovascular health plan The European research infrastructure for translational medicine (EATRIS) welcomes the EU Cardiovascular Health Plan and strongly supports a dedicated pillar on stroke, a leading cause of death, disability, and health-system costs in Europe.
Cardiovascular disease (CVD) is Europes leading public health challenge, but beyond mortality it means years lived with disability, strain on families, and rising costs for health and social systems. For those facing addictions, depression, or social exclusion, risks are significantly higher and often less visible.
Covering Letter ESVS Response to the EU Cardiovascular Health Plan (Call for Evidence) Dear Commission official, Dear DG SANTE team, The European Society for Vascular Surgery (ESVS) is pleased to submit the attached Position Note in response to the Commissions consultation on the forthcoming EU CardioVascular Health Plan.
The EU Structural Heart Disease (SHD) Coalition welcomes the European Commissions initiative to develop a comprehensive EU Cardiovascular Health (CVH) Plan, inspired by EU Beating Cancer Plan. To be impactful, the plan must address SHD, a subgroup of deadly CVDs that cannot be prevented through a healthy lifestyle but can be detected early and treated effectively.
Given the substantial risk factor posed by alcohol for the cardiovascular health of the people of Europe, Scottish Health Action on Alcohol Problems (SHAAP) endorses the submission made by the European Alcohol Policy Alliance (Eurocare).
The prevention of cardiovascular diseases is of vital importance in acquiring healthy lifestyle habits from childhood onwards, and it is therefore essential to include teachers in this type of strategy. This healthy lifestyle should be acquired within the family and strengthened at school. The promotion of a Mediterranean type of diet with its Atlantic and Nordic variants is crucial.
Filed in Spanish · English published by the European Commission
Large cohort studies, including atomic bomb survivors, radiotherapy patients, occupationally exposed workers, and Chernobyl and other accident cohorts, show an increased risk of cardiovascular disease (CVD)particularly coronary heart disease, stroke, and heart failurefollowing ionising radiation exposure.
Federal Agency for Nuclear Control (FANC) - Belgium Feedback for the EU Cardiovascular Health Plan Medical imaging procedures involving ionising radiation play a central role in the diagnosis, treatment, and follow-up of cardiovascular diseases. These include interventional cardiology, vascular angiography, myocardial scintigraphy, and cardiac computed tomography (CT).
The cardiology department of Cliniques universitaires Saint-Luc (UCLouvain) welcomes the European Commissions commitment to an ambitious Cardiovascular Health Plan for Europe. From our point of view, improving cardiovascular prevention at the population level requires a comprehensive approach that integrates public health policies, the social environment, and individual behaviors.
Dear EU Commission, The Institute for the Study and Education on Thrombosis and Antithrombotic Therapy welcomes the opportunity to contribute to the EU Cardiovascular Health Plan consultation. As a scientific medical society dedicated to improving cardiovascular outcomes through research, education, and clinical excellence, we strongly support the development of a comprehensive strategy to reduce the burden of…
The Heart Centre at Copenhagen University Hospital welcomes the forthcoming EU Cardiovascular Health Plan. It is an important and timely initiative that addresses the leading cause of premature mortality in the European Union. We strongly support the key action areas outlined: prevention; early detection and screening; and management, care and rehabilitation.
EULAR welcomes EU efforts to reduce the prevalence and burden of non-communicable diseases (NCDs) through the Healthier Together Initiative, Europes Beating Cancer Plan, and EU Cardiovascular Health Plan. However, we believe that current policy gives insufficient focus to comorbidity: the increased risk of one non-communicable disease causing or exacerbating the development of another potentially more serious…
Digestive health is integral to cardiovascular health. United European Gastroenterology (UEG), the leading non-profit organisation for excellence in digestive health representing over 50,000 specialists across all European member states, urges the European Commission to ensure that the Cardiovascular Health Plan fully recognises these interconnections and integrates strategies that address them.
AstraZeneca welcomes the European Commissions commitment to an ambitious Cardiovascular Health Plan for Europe aiming for lasting health and economic benefits across Member States. To realise this vision, the Plan must embrace an integrated, holistic cardio-renal-metabolic (CVRM) approach, grounded in scientific consensus on shared risk factors and multimorbidity.
For the EU cardiovascular health plan, and related to our activity as an Expert Center for Rare Genetic Cardiovascular Diseases, member of the ERN GUARD HEART and affiliated to the ERN VASCERN, I propose as one of the key strategic focuses sudden cardiac death in the young.
Submission to the European Alliance for Cardiovascular Health on the EU Cardiovascular Health Plan [THR and the role of nicotine products] Character count: 3,381 (including spaces and excluding references) I am an independent global health scholar with a background in the biomedical sciences and global health policy.
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
Diabetes Federation of Ireland supports IDF Europe's contribution. Diabetes Federation of Ireland supports the position of the International Diabetes Federation Europe (IDFE), an umbrella organisation of 73 national diabetes associations across 26 EU countries, representing both people living with diabetes (PwD) and healthcare professionals (HCPs).
A specific focus of the EUs Cardiovascular Disease Plan should be on one of the most burdensome cardiovascular diseases: Atrial Fibrillation and how to improve timely diagnosis and care through dedicated patient pathways to avoid the long-term consequences Stroke and Heart Failure. Atrial fibrillation (AF) is the most common type of arrhythmia, a problem with the rate or rhythm of the heartbeat.
Cardiovascular diseases are the leading cause of death in Europe, with more than 1.7 million deaths per year. One of the main risk factors is smoking, of which health damage is widely documented. Prevention therefore necessarily requires strategies to reduce smoking. However, despite decades of public policies, millions of Europeans continue to smoke.
Filed in French · English published by the European Commission
Submission to the European Commission Consultation on the EU Cardiovascular Health Plan on behalf of the Lp(a) International Task Force Lipoprotein(a) [Lp(a)] is one of the strongest inherited and causal risk factors for cardiovascular disease, affecting one in five Europeans. Despite this prevalence, testing rates remain at only 12%.
Submission to the EU Cardiovascular Health Plan Consultation From: All-Ukrainian Association of preventive cardiology and rehabilitation Why Ukraines Experience Matters Ukraines ongoing war has created extreme conditionsconstant stress, displacement, and disrupted healthcarethat have significantly impacted cardiovascular health.
We very much welcome the Commissions initiative to establish an EU Cardiovascular Health Plan, particularly its emphasis on prevention, screening, and early detection. However, we believe that the reference to early detection could be significantly strengthened by explicitly including acute cardiovascular conditions that require extremely urgent recognition and treatment.
Amgen welcomes the European Commissions ambitions for the upcoming EU Cardiovascular Health Plan. As a global biotechnology company with a strong European presence, we are committed to advancing scientific breakthroughs and ensuring they translate into meaningful outcomes for patients. Amgen is aligned with the EFPIA position on the forthcoming EU Cardiovascular Health Plan.
Alcohol related harm, including mortality and morbidity, are record high in the EU and cardiovascular disease is the leading category of alcohol attributable mortality. Alcohol consumption is estimated to be responsible for close to 50,000 CVD deaths annually in the EU. 1 Europe has the highest rates of alcohol consumption per person, the highest prevalence of heavy episodic (i.e.
The Robert Koch Institute is Germanys public health institute and the German Federal Governments central institution in the field of biomedicine. Our mission is to protect and improve the health of the population.
Employers of Poland call for the EU Cardiovascular Health Plan to prioritize Chronic Kidney Disease (CKD) as a central pillar, recognizing its deep interconnection with cardiovascular disease (CVD), type 2 diabetes, and hypertension. CKD affects nearly 9% of the global population and is projected to become the fifth leading cause of death by 2050.
Kenvue supports the European Commissions intention to develop an EU Cardiovascular Health Plan, recognising this as a critical opportunity to implement actions that deliver tangible benefits for individuals, governments, and stakeholders across the EU.
We would like to thank the Commission for bringing forward the burden of cardiovascular diseases (CVDs) and for highlighting that most of these conditions are preventable. The focus on prevention is very welcome and essential in reducing both the health and societal costs caused by CVDs.
EuropeActive & its undersigned National Associations welcome the initiative for an EU CVD Plan. We strongly support the focus on prevention, as tackling risk factors and early chronic disease is the most effective way to protect citizens health, reduce suffering, and ease the immense economic burden of treatments & hospitalisations.
The European Alliance for Cardiovascular Health (EACH) brings together 22 leading European and international organisations around joint activities to promote cardiovascular health as a policy priority at EU level. In April 2025 we published "A European Cardiovascular Health Plan: The Roadmap", attached to this feedback.
RESIL-Card, a project co-funded under the EU4Health Work Programme, supports the European (EU) Commissions initiative to develop a comprehensive EU Cardiovascular Health Plan, aiming to reduce the burden of cardiovascular diseases (CVD) and to strengthen health systems in Europe.
AFNET welcomes the initiative for an EU cardiovascular health plan to improve the lives of millions of people in Europe, to increase innovation, and to boost the competitiveness of the EU health industry. This is important in view of the impact of cardiovascular diseases on health in the EU and in view of the opportunities that can be created by such a plan for EU citizens and for life sciences in the EU.
The Centre for Economic and Market Analyses (CETA), in cooperation with leading Czech experts, recently prepared the study Strategic Priorities for the National Cardiovascular Plan 20232033. Drawing on this experience, we welcome the European Commissions initiative to create a comprehensive EU Plan for Cardiovascular Health and would like to highlight several points relevant at the European level: 1.Cardiovascular…
The Dutch Cardiovascular Alliance (DCVA) is a partnership of 25 partners, including patients, researchers, healthcare professionals, industry and health funds. We are working together to reduce the burden of cardiovascular disease by 25 % by 2030 through prevention, early detection, optimal care organisation and the use of data and innovations. We endorse the ambition for an EU-wide cardiovascular health plan.
Filed in Dutch · English published by the European Commission
The European Society of Radiology (ESR) welcomes the EU plan to reduce the burden of cardiovascular diseases (CVDs) focused on prevention, early detection and screening, as well as management, care and rehabilitation. The EU Cardiovascular Health Plan (CVHP) offers a key opportunity to not only address CVD but also advance broader public health, equity, and economic goals.
Submission to the European Alliance for Cardiovascular Health on the EU Cardiovascular Health Plan I welcome the opportunity to provide insights for the EU Cardiovascular Health Plan and support the target of reducing premature cardiovascular disease (CVD) in the EU.
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
Alcohol-related harm, including mortality and morbidity, reaches record levels in the EU, with cardiovascular diseases being the leading cause of alcohol-related deaths. It is estimated that alcohol consumption is responsible for almost 50.000 cardiovascular deaths per year in the EU. Europe has the highest alcohol consumption per capita, the highest prevalence of episodisic alcohol consumption (i.e.
Filed in German · English published by the European Commission
The Comité Européen des Entreprises Vins (CEEV) - the voice of EU wine companies - shares the ambition of the European Commission and Member States to improve public health and is committed to its social responsibility.
Contribution of the Slovak Republic to the EU Cardiovascular Health Plan Consultation In Slovakia, stroke affects approximately 17,000 people annually. Cardiovascular diseases remain the leading cause of death, with stroke representing a significant share of this burden. In recent years, the incidence of stroke has been increasing, including among younger patients under 60.
Scientific research shows that whole grains lower the risk of cardiovascular disease. According to the Belgian High Council of Health, just 125 grams of whole grains (about 4 slices of whole grain bread) daily is linked to reduced heart disease risk. Despite their benefits in preventing heart disease and type 2 diabetes, whole grain intake remains low in many EU countries.
ACPAN Romania urges the European Commission to recognize the evidence supporting the harm reduction and smoking cessation potential of e-cigarettes, heated tobacco products, and other low-risk nicotine products. Integrating these alternatives into the EU Cardiovascular Health Plan will save lives, reduce the burden of CVD, and support informed, sustainable public health strategies.
Patient organisation Stichting VrouwenHart warmly welcomes the creation of the EU Cardiovascular Health Plan. As a patient organisation founded by and for women with cardiovascular disease (CVD), we see every day how the lives of women are affected (and their loved ones and employers) by conditions that are common, genetic or gender-specific, yet preventable once recognised and properly managed.
As an international alliance of heart patient organisations, Global Heart Hub welcomes the Commissions leadership and calls for a boldly inclusive EU Cardiovascular Health Plan that truly reflects patient realities and delivers meaningful progress for everyone affected by heart disease.
The TUM University Hospital German Heart Center strongly welcomes the European Unions initiative to establish a comprehensive EU Cardiovascular Health Plan. Cardiovascular disease (CVD) remains the leading cause of death in Europe, representing a tremendous burden for patients, healthcare systems, and societies. In 2021, CVD accounted for 32% of all deaths in the EU.
The Italian Society of Geriatric Cardiology (SICGe) strongly advocate for the inclusion of community-based cardiovascular screening and prevention programs in the CVH Plan. Such initiatives are vital to addressing the growing burden of cardiovascular diseases (CVD) in the ageing population. The PREVASC 2 project exemplifies the importance of leveraging the "Third Mission" of universities to achieve this goal.
The Irish Heart Foundation welcomes the development of the EU CVH plan and makes the following recommendations relevant to all forms of CVD, including heart disease, stroke and blood vessel disease: Prevention The EU must use its regulatory powers more effectively in key areas of prevention such as nicotine addiction, healthy eating and childhood obesity.
spiritsEUROPE welcomes the European Commissions ambition to improve cardiovascular health and supports efforts to strengthen prevention, particularly through measures that address unhealthy behaviours and reduce risk factors for cardiovascular disease (CVD).
EuropeActive & its undersigned National Associations welcome the initiative for an EU CVD Plan. We strongly support the focus on prevention, as tackling risk factors and early chronic disease is the most effective way to protect citizens health, reduce suffering, and ease the immense economic burden of treatments & hospitalisations.
Herlev Hospital Response to the EU Cardiovascular Health Plan Call for Evidence As one of Denmarks largest hospitals and a key provider of cardiovascular care, Herlev Hospital welcomes the EUs initiative to develop a comprehensive Cardiovascular Health Plan. This is an important opportunity to rethink how we prevent the leading cause of death in Europe, cardiovascular disease driven by atherosclerosis.
The Chamber of Commerce "FARMACJA POLSKA," representing key stakeholders in the Polish pharmaceutical sector, commends the European Commission's vital initiative to establish a dedicated EU Cardiovascular Health (CVH) Plan. As cardiovascular disease (CVD) remains the foremost cause of mortality in Europe, this focused effort is both timely and essential.
Cardio- and neurovascular diseases are not only the leading cause of death in Germany, but also account for 13% of all healthcare costs, 56.7 billion of 431.8 billion euros. Around four in ten deaths in Germany in 2019 can be attributed to behavioral risk factors such as smoking, diet, alcohol consumption and low physical activity.
With more than 13 million new cases diagnosed annually and costs amounting to 282 billion per year, the burden of Cardiovascular Disease on patients, healthcare systems and society is staggering. EFPIA therefore supports a robust and well-resourced EU CVH Plan that sets out actions with clear added value, clear objectives and measurable targets, e.g. the reduction of premature and preventable deaths by 1/3 by 2030.
Steno Diabetes Center Copenhagen Response to the EU Cardiovascular Health Plan Call for Evidence Steno Diabetes Center Copenhagen (SDCC) welcomes the European Com-missions initiative to create a comprehensive cardiovascular health plan.
Integrating Influenza Vaccination as Cardiovascular Prevention. This proposal is made on behalf of the Italian Society of Cardiovascular Prevention which has long advocated the importance of Flu vaccination as an important preventive measure in elderly patients (65 years or more).
Cardiovascular disease (CVD) is recognised as the main cause of mortality in the European Union (EU) and its health and economic burden is very high. The prevalence of SAS is largely influenced by lifestyle factors, diet, physical activity, smoking and alcohol consumption, which prevent or reduce, as well as distant the development of these diseases and their complications.
Filed in Latvian · English published by the European Commission
Competere Policies for Sustainable Development, a policy institute that promotes balanced lifestyles and innovation-driven policies, thanks the Commission for the opportunity to provide feedback to this call for evidence. We welcome the initiative to address cardiovascular diseases (CVDs), a chronic pandemic of the 21st century, through prevention, early detection, treatment, and innovation.
The Spanish Society of Cardiology (SEC) welcomes the opportunity to contribute to the development of the EU Cardiovascular Health Plan. As a scientific society representing more than 8,500 professionals and 18,000 cardiovascular patients in Spain, we consider it essential that this Plan is based on the three strategic pillars: prevention, patient-centred care and research, which are essential to reduce the burden of…
IEVA - the Independent European Vape Alliance - as the umbrella organisation representing national associations, manufacturers, distributors, and specialised retailers of vaping products across the EU, would like to share its contribution to the European Commissions public consultation on the EU Cardiovascular Plan.
EU in Demographic Transformation The Role of Cardiovascular Health Prevention to Build a Competitive Advantage Situational Analysis through the Lens of Demography The populations of EU Member States are undergoing an irreversible demographic transition (1).
Cardiovascular disease (CVD) is Europes leading cause of death: one in three deaths, 20% of premature deaths, 13 million new cases yearly, and 282 billion in costs. Tackling CVD requires an EU-level response that goes beyond national action, combining prevention, innovation, and equity. Vision for the Plan The forthcoming EU CVH Plan should set ambitious, measurable targets (e.g.
Scientific research clearly indicates that the consumption of whole grains reduces the risk of cardiovascular diseases. For example: according to the Dutch Health Council, consumption of only 90 grams of whole grains (which equals 3 slices of whole grain bread) per day is associated with a 25% lower risk on heart disease.
The Commissions Cardiovascular Health Plan means progress and reduced consumer-risk for the entirety of the EU! Public health scientists and professionals advocating for risk reduction for the population of the EU, including myself, welcome advances in regulation.
For many years, Deutsche Herzstiftung has been working at both national and international level to improve care for heart patients, increase prevention, education and support research. It funds numerous patient-related research projects every year in Germany and carries out important work with nationwide heart weeks and targeted information campaigns to identify risk factors early and provide patients with timely…
Filed in German · English published by the European Commission
It is my sincere pleasure to contribute to this Consultation. I am writing to highlight the profound importance of integrating evidence-based Tobacco Harm Reduction (THR) comprehensively into the EU Cardiovascular Health Plan, thereby ensuring a maximum positive impact for public health across Europe.
The European Union must act effectively for a new plan of action to improve the cardiovascular health burden of European citizens. In our recent Narrative Review, we highlight the urgent need for coordinated action across member states to address the persistent and growing burden of cardiovascular disease, which remains the leading cause of death in the EU.
NFN (Istituto Nazionale di Fisica nucleare) is a national public research institute in ITALY. We are leading national and European project in the field of High Performance Computing (HPC) and Artificial intelligence (AI).
The Oral Health Foundation welcomes the European Commissions initiative to develop a comprehensive EU Cardiovascular Health Plan and strongly advocates for oral health to be fully integrated into this strategy. Cardiovascular diseases are the leading cause of death in the EU, while oral diseases are the most prevalent non-communicable diseases worldwide, affecting billions of people and costing Europe around 90…
The Aortic Association welcomes the opportunity to provide evidence for the European Cardiovascular Health Plan, which follows the Council Conclusion on the improvement of cardiovascular health in the European Union. To achieve maximum impact, the plan should follow the Council's considerations that cardiovascular diseases (CVDs) include diseases of the aorta.
Cardisio GmbH, founded in 2016 and headquartered in Frankfurt am Main in Germany, is committed to the early detection of heart disease. In Cardisios vision for the future, everyone has access to a scientifically proven, highly accurate, and non-invasive screening procedure for heart diseases that is easy to use, examiner-independent, and affordable.
Dear Madam/Sir, As a General Manager of the HCM Patient Foundation (www.hcmpatient.eu), an organization which deals with problems of patients with Hypertrophic Cardiomyopathy in the EU, I meet regularly with patients with that disease from the whole European Union. In order to understand better the needs of HCM patients we deployed a survey which got 337 replies from 18 countries.
The Hellenic College of Cardiology strongly welcomes the European Commissions initiative to establish a comprehensive EU plan for cardiovascular health. This is a historic and visionary step toward improving cardiovascular outcomes across Europe, and we are committed to supporting its implementation through education, research, and clinical collaboration.
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality in Lithuania, with particularly high incidence rates observed across the population. Recognizing the urgency of this public health challenge, Lithuania is actively contributing to the development of the European Union Cardiovascular Health Strategy and supports the creation of a comprehensive EU Plan for Cardiovascular Health.
I warmly commend the European Commission for initiating the EU Plan for Cardiovascular Health. This is a visionary and timely step toward addressing the leading cause of death and disability across the continent. It reflects a deep understanding of the urgent need for coordinated, science-based action and sets the stage for meaningful progress in cardiovascular health.
With reference to the recent consultation launched by the European Commission on the European cardiovascular health plan, expiring in 15.9.2025, the Umbria Region, in cooperation with the Perugia Hospital Authority (Director of Dr Maurizio de Pinto), has drafted a draft that we would like to bring to your attention.
Filed in Italian · English published by the European Commission
Warszawa, 10 września 2025 r. Stanowisko Federacji Przedsiębiorców Polskich (FPP) w odpowiedzi na zaproszenie Komisji Europejskiej do składania uwag dotyczących inicjatywy „Unijny plan dotyczący zdrowia układu krążenia” Inicjatywa Komisji Europejskiej (KE) „Unijny plan dotyczący zdrowia układu krążenia” ma na celu poprawę zdrowia publicznego na poziomie indywidualnym i ogólnospołecznym oraz przyczynienie się do…
Filed in Polish · English published by the European Commission
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
KPMG Healthcare welcomes the European Commissions initiative to develop a comprehensive EU Cardiovascular Health Plan. Cardiovascular diseases (CVDs) remain the leading cause of mortality and morbidity in Europe, with significant social and economic costs. A pan-European approach that complements national strategies is both timely and necessary.
As Professor of Medicine at the University and Medicines Coordinator of EAP Albacete 5, I am very pleased with the European Commission’s Cardi-cular Health Plan. Cardiovascular diseases are undoubtedly the main cause of death in Western countries and therefore their prevention and early detection are the first steps to be taken.
Filed in Spanish · English published by the European Commission
Francesco Moscone Ca Foscari, University of Venice, University of Brunel, and Universita Cattolica del Sacro Cuore. As a health economics researcher specializing in lifestyle-related risk factors, Professor of Public Economics at the Università Ca' Foscari Venezia, Head of the Observatory of the Economics of Public Health at ALTEMS [1, 2, 3, 4, 5] and lead of the Healthcare Management and Wellbeing research area at…
The Smoke Free Partnership (SFP) is a coalition of nearly 60 public health organisations across Europe and globally. It supports the implementation of the WHO Framework Convention on Tobacco Control (FCTC) and promotes tobacco control policy and research.
I wholeheartedly support the EU Cardiovascular Health Plan's ambitious goals to reduce premature cardiovascular deaths across Europe. In my daily practice, I witness firsthand the devastating impact of cardiovascular disease (CVD) on individuals and families.
I would like to contribute to the debate on the EU Cardiovascular Health Plan by presenting the perspective of a health economist with extensive experience and knowledge of the impact of fiscal policies on health policy outcomes.
I write in strong support of the EU Cardiovascular Health Plan and its goals to reduce cardiovascular disease (CVD). This initiative represents an important step forward in tackling Europe's leading cause of death and disability. However, the plan does not fully address health disparities among Member States, and it risks being a lost opportunity. Cardiovascular mortality rates differ widely across the EU.
Behavioral and Fiscal Tools to Reduce Cardiovascular Risk Emanuele Bracco (Economist, University of Verona) Cardiovascular disease continues to pose a major challenge across the EU, particularly among lower-income populations.
Prof. Dr. Salvatore Barbaro Johannes-Gutenberg University, Mainz To the European Commission, the Commission’s initiative on cardiovascular health rightly stresses prevention, yet its success will depend to a significant degree on whether fiscal instruments are deployed strategically.
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
The Belgian Diabetes Association (Association du Diabète, ADD) strongly supports the EUDF Shadow Cardiovascular Plan and its call to fully integrate diabetes within EU cardiovascular policy. The Shadow Plan provides a coherent, evidence-based roadmap that matches Belgiums priorities on prevention, equity, and innovation.
We, the non-governmental organisation in the Republic of Moldova, the International Centre for Prevention and Information on Addictions, are committed to changing the perception of addictions by implementing the risk reduction strategy and helping to reduce the burden of non-communicable diseases (NCDs), many of which are cardiovascular diseases (CVDs).
Filed in Romanian · English published by the European Commission
The European Association for the Study of the Liver (EASL) welcomes the European Commissions commitment to improving cardiovascular health and recognises the potential of this initiative to deliver significant benefits for citizens, healthcare systems, and the EU economy.
We appreciate the initiative of the European Commission to launch an EU plan for cardiovascular health. The call for evidence clearly presents the reasons why such a plan is desirable, noting that cardiovascular diseases are the leading cause of death in the EU and are projected to increase in the near future.
Proposals from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Pathways from early detection and diagnosis to referral and treatment. Heart failure (HF) is still diagnosed too late and not adequately prevented before its clinical manifestations.
Diabetes, obesity and cardiovascular diseases (CVD) are closely interconnected. Therefore, the upcoming Cardiovascular (CV) Health Plan should address the triangle of diabetes, obesity and CVD. The effective prevention, detection and management of all types of diabetes is key to preventing CVD.
A Blueprint for EU Cardiovascular Health: The Case for Systematic, Proactive Screening Rather than waiting for individuals to present with unrelated health concerns, a proactive, systematic approach to prevention is demonstrably more effective at identifying at-risk populations.
Panos E. Vardas I welcome the decision of the European Union to recognize cardiovascular diseases as a major indeed the leading cause of morbidity and mortality in Europe and beyond. The European Society of Cardiology, and more specifically the European Heart Agency in Brussels, has worked methodically and systematically to document and highlight this problem.
We welcome the European Commissions initiative to establish a comprehensive EU Cardiovascular Health Plan. As a patient organisation representing people living with heart valve disease (HVD), we stress the need for the Plan to address both the broad burden of CVD and the specific unmet needs of patients with valve disorders.
The EU Action Plan for Cardiovascular Health should focus primarily on the prevention of cardiovascular diseases (CVD), which are responsible for the majority of premature deaths in Europe. The main cause of these diseases is an unhealthy diet, characterised by low nutrient food consumption and excessive consumption of salt, saturated fat, red meat and processed meat.
Filed in Italian · English published by the European Commission
Dear European Commission, the European Union Plan for cardiovascular health must focus on actions with tangible benefits for citizens, governments and stakeholders across the Union. At the same time, the Plan must include prevention measures as a key pillar for reducing cardiovascular disease (CVD).
Filed in Romanian · English published by the European Commission
️ Feedback EU Cardiovascular Health Plan (Call for Evidence) Focus on Valvular Heart Disease Introduction I am Almudena Aguilera Saborido, cardiologist, Clinical Coordinator Heart Valve Unit, Cardiac Imaging Specialist, working in Virgen del Rocio Hosptial/Seville/Spain.
Contribution to the EU Cardiovascular Health Plan Call for Evidence Submitted by: Anayanci Masís-Vargas, MSc., PhD. Title: CEO and Founder, NutriXQ Expertise: Neuroscience, Metabolism, and Nutrition Science Date: September 2025 Executive Summary As a neuroscientist and nutritionist with extensive research experience in metabolic health, I submit this contribution to advocate for a paradigm shift in cardiovascular…
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
Fresh produce: A natural ally in the EU’s strategy preventing cardiovascular diseases The International Fresh Produce Association (IFPA) warmly welcomes the European Commission’s initiative to develop an EU Cardiovascular Health Action Plan.
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
I support the EuropeanCommissions intention to develop an EU Cardiovascular Health Plan, recognising thisas a critical opportunity to implement actions that deliver tangible benefits forindividuals, governments, and stakeholders across the EU.
Long version: Feedback to the EU Cardiovascular Health Plan (Initiative 14755) Submitted by ERN GUARD-Heart – European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart ERN GUARD-Heart welcomes the European Commission’s initiative to develop a comprehensive EU Cardiovascular Health Plan.
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
The pulse. Think tank cardiovascular disease is committed to effectively addressing cardiovascular diseases as the global cause of death n°1: Through an integrated approach, we want to improve the health situation of the people concerned. We are convinced: Cardiovascular diseases should not be considered in isolation when it comes to providing good prevention and care structures and concrete treatment solutions.
Filed in German · English published by the European Commission
Abstract Fondazione Longevitas The Fondazione Longevitas welcomes the European Commissions decision to prioritise cardiovascular health through the creation of an EU Cardiovascular Health (CVH) Plan. Such a plan can transform how Member States prevent, detect, and treat cardiovascular diseases, provided that structural heart diseases (SHDs) and heart failure are placed at its core, alongside strong measures on…
Life expectancy increases every year in Europe; in Spain, the average is above the age of 80, when 60 % of people over the age of 65 suffer from at least one chronic disease. Among these, cardiovascular and osteoarticular diseases are particularly common.
Filed in Spanish · English published by the European Commission
EU Cardiovascular Health Plan: Open Public Consultation Dear Consultation Team, Thank you for the opportunity to provide feedback on the upcoming EU Cardiovascular Health Plan. I welcome the Commissions ambition to develop a comprehensive strategy, as cardiovascular diseases are the leading cause of death in the EU and disproportionately affect socially and economically marginalised groups.
i am surprised that obesity is very few mentioned in this Cv health plan as this is the main cause of CV diseaeses may i request to increase the visibility of prevention and treatment of obesity in the plan. Obesity must be recognised as a gateway disease and a primary cause of CVD. The inclusion of comprehensive actions to address and manage obesity within the Cardiovascular Health Plan i thank you forwards
On behalf of the Spanish Association of Nurses in Cardiology (AEEC), we are writing to you to participate with interest in the public consultation on the future European Cardial Health Plan. We value this initiative, which is key to addressing cardiovascular disease (CVD), the leading cause of death in Europe and with an annual economic cost of more than EUR 280.000 billion.
Filed in Spanish · English published by the European Commission
Greek Vapers Alliance (GVA) is the official voice of Greek and Cypriot consumers of alternative nicotine products. We represent the experience of thousands of adult former smokers who managed to leave cigarettes behind with the help of smoke-free alternatives such as e-cigarettes. Today, these people enjoy a life away from smoke and its harms, having significantly reduced risks to their heart and overall health.
Contribution of the University of Milan Center for the Study and Research on Obesity (CSRO) and INLANE Network to the EU Cardiovascular Health Plan Call for Evidence (2025) The Center for the Study and Research on Obesity (CSRO) of the University of Milan has been a pioneer in considering obesity as a major cardiovascular risk factor and a systemic disease, promoting clinical and translational research, education…
Background and situation of the stroke in Spain. Stroke is one of the most impactful diseases in the world. The data are strong: stroke is the second cause of death, the third cause of disability and one of the leading causes of dementia worldwide. The age-standardised incidence of stroke on younger people (i.e. < 55) is increasing in both high and low- and middle-income countries.
Filed in Spanish · English published by the European Commission
While I appreciate the attention being paid to cardiovascular disease prevention in the current policy proposal, I believe it falls short in addressing one of the most significant underlying causes: obesity. From my daily experience working in a rehabilitation center (Het Zeepreventorium), particularly with young adults struggling with obesity, I witness firsthand the strong association between obesity and key…
Greek Vapers Alliance (GVA) is the official voice of Greek and Cypriot consumers of alternative nicotine products. We represent the experience of thousands of adult former smokers who managed to leave cigarettes behind with the help of smoke-free alternatives such as e-cigarettes. Today, these people enjoy a life away from smoke and its harms, having significantly reduced risks to their heart and overall health.
· · filed 8 Sept 2025 · same text as 1 other organization · source
Endorsement of the Platform for Better Oral Health in Europes Response to the EU Cardiovascular Health Plan This submission fully endorses the detailed response provided by the Platform for Better Oral Health in Europe to the European Commissions Call for Evidence on the EU Cardiovascular Health Plan.
The use of harm reduction tools, such as e-cigarettes, is a crucial strategy to tackle the harm caused by traditional smoking. By eliminating tobacco combustion, these devices significantly reduce exposure to carcinogenic and toxic substances. Harnessing these alternatives provides a concrete way to drastically reduce premature deaths and smoke-related diseases, which claim millions of global casualties every year.
Filed in Italian · English published by the European Commission
The European Hospital and Healthcare Federation (HOPE), representing national hospital associations and healthcare organisations across Europe, welcomes the European Commissions initiative to develop a comprehensive EU Cardiovascular Health Plan.
This submission fully endorses the detailed response provided by the Platform for Better Oral Health in Europe to the European Commissions Call for Evidence on the EU Cardiovascular Health Plan. We support the Platforms call to integrate oral health into the core of the EUs strategy to tackle cardiovascular diseases (CVDs).
The World Vapers Alliance welcomes the European Commissions initiative to develop a comprehensive Cardiovascular Health Plan. In our attached contribution, we highlight the growing body of scientific evidence showing that the cardiovascular risks of electronic cigarettes are substantially lower than those of smoking, and that smokers who switch to vaping experience measurable improvements in cardiovascular health…
VASCage (COMET centre, FFG, Austria: https://vascage.at) is one of the few international stroke research centres in Europe with a clinical and translational focus. Our goals align with those of the EU Cardiovascular Health Plan, such as improving the health of millions of citizens and increasing the innovation and market competitiveness of the EU health industry.
SLOVENIAN STROKE SUPPORT SOCIETY (SSSS) SLOVENIAN STROKE SUPPORT SOCIETY (SSSS) has been launched in 1990 to support stroke survivors and their families. SSSS is operating on local level via stroke clubs and on national level. Stroke is devastating illness, highly and long-term impacting the life of stroke survivors and their families. Therefore, the SSSS supports the EU cardiovascular health plan.
Prevention is better than cure. The most significant risk factor for developing cardiovascular disease is cigarette smoking. Tobacco smoke contains numerous toxic and carcinogenic compounds. https://www.rynekzdrowia.pl/Plik/207961.html Reducing cigarette consumption should also be a key goal of the EU cardiovascular health plan. If so there should be two most important goals of tobacco control policy: 1.
Theodosios Bisdas, MD, PhD, FACS Vascular Surgeon, Athens Medical Center, Athens, Greece I strongly welcome the European Commissions initiative to develop an ambitious EU Cardiovascular Health Plan. Cardiovascular disease (CVD) remains the leading cause of death and disability in Europe, with more than 10,000 deaths every day and an annual cost exceeding 210 billion.
Infobees supports the European Unions intention to develop a Cardiovascular Health Plan. Obesity is one of the leading causes of cardiovascular disease. However, it is more than just a contributing factorit is a disease in its own right. Recognizing obesity as a disease, and raising public awareness of this fact, is essential for two reasons: 1°) It helps reduce stigma.
I’m giving this feedback on behalf of the Hippocrates-Association of General Practice/Family Medicine of Greece, as the Honorary Secretary. Hippocrates has now 2800 members. More info at www.hippocratesgp.gr The feedback is included in the attached file.
Filed in Greek · English published by the European Commission
· · filed 5 Sept 2025 · same text as 1 other organization · source
Endorsement of the Platform for Better Oral Health in Europes Response to the EU Cardiovascular Health Plan This submission fully endorses the detailed response provided by the Platform for Better Oral Health in Europe to the European Commissions Call for Evidence on the EU Cardiovascular Health Plan.
Obesity should be recognised as an entry disease and a major cause of cardiovascular disease. Comprehensive measures to combat and manage obesity need to be integrated into the cardiovascular health plan. Professor Jean-Paul THISSEN UCLouvain
Filed in French · English published by the European Commission
The Boscacci Foundation welcomes the European Commission's initiative to develop a comprehensive plan for cardiovascular health, recognizing the urgency of addressing the leading cause of mortality in the Union.
Endorsement of the Platform for Better Oral Health in Europes Response to the EU Cardiovascular Health Plan This submission fully endorses the detailed response provided by the Platform for Better Oral Health in Europe to the European Commissions Call for Evidence on the EU Cardiovascular Health Plan.
To: The European Commission Subject to: European Cardiovascular Disease Plan Info: Article Prof. Dr. Hristina Nikolova Group, DMN, Chairman of the Bulgarian ophthalmology company Dear representatives of the European Commission, As ophthalmology specialists, we would like to present their contribution to the development of the European Plan for Cardiovascular Diseases (GCC).
Filed in Bulgarian · English published by the European Commission
Contribution to the Call for Evidence for the EU Cardiovascular Health Plan The Mediterranean Observatory on Harm Reduction (MOHRE) is a multidisciplinary network composed of physicians, scientists, and health communication experts, committed to the identification and promotion of evidence-based strategies aimed at reducing preventable morbidity and mortality associated with high-risk behaviors and lifestyle-related…
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
The economic case: health as growth policy. Treatment-heavy systems extend life but often with more years lived in disability and rising costs. Prevention compresses morbidity and supports labour force participation.
As a member of the European Association for the Study of Obesity (EASO), I believe obesity should be addressed as a primary prevention measure to improve cardiovascular health in the EU. Therefore, obesity should be recognised as a gateway disease for the development of CVD. Additionally, the plan should include actions to address obesity as a primary prevention tool to reduce CVD prevalence.
The attached document is an updated consensus of 2024 on smoking and vascular risk, carried out by Spanish-Latin American scientific societies leading in hypertension and vascular risk. It summarises the impacts of smoking on cardiovascular and general health and includes the professional position on new strategies to reduce harm to people who fail to stop smoking. The impact of smoking on Vascular Risk.
Filed in Spanish · English published by the European Commission
Dear, as a member of the Obesity clinic KORTRIJK AZ Groeninge, as a member of the Baso and EASO and as a practising endocrinologist, I express my concern about the EU Cardiovascular health plan. In my daily clinical practice, I mainly deal with patients suffering from the disease Obesity, which is a gateway to more than 200 other pathologists including type 2 diabetes, OSAS, certain cardinomes, mental health, etc.
Filed in Dutch · English published by the European Commission
Contribution to the call for evidence for the upcoming EU Cardiovascular Health Plan The EU Cardiovascular Health Plan aims to help Member States reduce the number of people falling ill with cardiovascular diseases and prevent premature deaths for those with existing conditions or risk factors, such as obesity, high blood pressure or related comorbidities that increase their risk of developing heart disease.
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
As an endocrinologist in Belgium, member of BASO, I realize that in fact less ( or nothing) is said about the topic of obesity and its influence on cardiovascular health. But we all know that managing obesity is a major issue to fight to diminish the CV events.
The BEDF (Belgian Diabetes Forum) calls for diabetes to be fully integrated into cardiovascular disease (CVD) strategies, given the deep interconnection between diabetes, obesity, and CVD. BEDF fully supports the 'EUDF Shadow CV Plan' It provides a comprehensive, evidence-based roadmap for integrating diabetes into the EU Cardiovascular Plan.
The European Union faces significant healthcare challenges, including an aging population, rising chronic illness prevalence, and a shortage of healthcare professionals. In the field of cardiology, these challenges are particularly acute, with heart disease remaining a leading cause of morbidity and mortality.
Endorsement of the Platform for Better Oral Health in Europes Response to the EU Cardiovascular Health Plan On behalf of the International Federation of Dental Hygienists (IFDH), representing over 30 member countries across the globe, this submission fully endorses the detailed response provided by the Platform for Better Oral Health in Europe to the European Commissions Call for Evidence on the EU Cardiovascular…
Integrating Oral Health into the EU Cardiovascular Health Plan Cardiovascular diseases (CVDs) are the leading cause of death in the EU, responsible for 1.7 million deaths annually and costing over 280 billion. As the EU develops its strategic response, it is essential to recognise oral health as a key component of systemic health and CVD prevention.
Dear Commission team, I support the Commissions plan to improve prevention, early detection, and care, as cardiovascular disease is a leading cause of death and a growing challenge for healthy ageing and productivity. The draft plan sets out priorities for addressing cardiovascular risk factors and highlights prevention as a central tool to improve population health.
Tromboza venoasă profundă și profilaxia acestei boli în cadrul EU Cardiovascular Health Plan. Context și magnitudine: Tromboza venoasă profundă (TVP) și embolismul pulmonar (EP) reprezintă o cauză majoră de morbiditate și mortalitate în Europa: >544.000 decese anual în UE, mai mult decât accidentele rutiere, cancerul de sân/prostată și HIV la un loc. 10 milioane cazuri noi pe an la nivel global.
Traditionally regarded as a male disease (CVD) is the number one killer of women worldwide. It also is a major cause of serious illness and disability, costly to healthcare systems and destroying womens quality of life. In the EU, CVD remains the top cause of death for women in each of the twenty-seven EU countries.
Dear Members of the European Commission, In my capacity as President of the Institute of Innovation, on behalf of the organisation, I welcome the initiative of the European Commission to create a European plan for cardiovascular health.
Filed in Bulgarian · English published by the European Commission
To whom this may concern, PHOENIX group welcomes the Commissions initiative aimed at addressing the major health burden of European citizens - cardiovascular diseases. We especially welcome the fact that the initiative will look at improving prevention, early detection and diagnosis.
Cardiovascular diseases are one of the biggest threats to public health in the European Union. They are a leading cause of mortality and disability, having a serious impact not only on the health of the individual, but also on the economy, the social system and the sustainability of health services.
Filed in Bulgarian · English published by the European Commission
The Swedish Heart-Lung Foundation welcomes the EUs initiative for a joint European CVD health plan and look forward to a plan that, in the future, will help prevent premature death and unnecessary suffering. EU and Sweden need a plan that goes beyond symbolic value and becomes a tool for real change.
In heart valve disease, women still are diagnosed too late, in comparison to male patients. I attach two recent papers from our group: female patients present later in the disease stage, with more pronounced symptoms and co-morbidity. This deserves large-scale attention.
I have over 20 years' experience in supporting people to stop smoking, and my clinical experience demonstrates without any doubt that non-combustible sources of nicotine are vital for helping people stop smoking.
Cardiovascular disease (CVD) is the single largest cause of death in Europe, responsible for millions of preventable deaths every year and placing a heavy burden on healthcare systems. While medical advances have improved treatment, prevention remains the most effective strategy.
Poor diet is responsible for a large proportion of NCD burden in Europe and globally (https://www.bmj.com/content/364/bmj.l296). Some important points on prevention: -prevention is a broad term and the most important types of prevention are primary prevention and secondary --primary prevention, it is essential that we create better opportunities for people to eat healthily and sustainably so they can avoid CVD in…
The Belgian Stroke Council welcomes the European Commissions initiative to develop an EU Cardiovascular Health Plan. Stroke is a leading cause of death and the primary cause of acquired long-term disability in Europe. It accounts for a substantial proportion of healthcare costs and loss of productivity, yet the majority of strokes are preventable.
I write in strong support of the EU Cardiovascular Health (CVH) Plan and its objective to reduce cardiovascular disease (CVD) by 33% by 2030. I recognize that achieving such a significant population-level outcome demands a comprehensive, pragmatic, and equitable approach that addresses the realities of diverse communities.
The Association of Dentists of the Republic of Moldova (ASRM), a public professional organization and successor of the Scientific Society of Dentists of the RSSM (founded in 1957), brings together medical professionals engaged in both research and clinical practice in the field of dentistry. Oral health is inseparably linked to overall health.
Comment by the Belgian vapour federation FeBeVa In the context of the EU cardiovascular health plan The Belgian vapour federation (FeBeVa) welcomes the European Union’s ambition to improve the cardiovascular health of citizens through prevention, early detection and innovation-based policies.
Filed in French · English published by the European Commission
We don't have valid and reliable measures of cardiovascular fitness in the EU population at any larger scale, only "sickness" measures such as confirmed chronic conditions. To do any proper preventive work in cardiovascular health, you need baseline measures for the population you want to prevent these conditions in.
We are the "Society of Substance Abuse Professionals," a non-governmental medical organization. We support the harm reduction approach for those with substance addiction disorders, which avoids forcing patients to suffer from withdrawal syndrome. Instead, we deploy an array of practical strategies to reduce the negative health and social consequences of substance, alcohol, and tobacco use.
The Heated Community Hub welcomes the European Commissions initiative on a comprehensive EU Plan for Cardiovascular Health. Our contribution highlights the significant role of tobacco smoking in cardiovascular disease and stresses the need to distinguish between the harms of combustion and nicotine.
Cardiovascular diseases (CVD) are the leading cause of death in Europe. As efforts intensify to strengthen CVD prevention, detection, and intervention, it is essential that any effective cardiovascular strategy includes a clear focus on chronic inflammatory skin diseases.
Cardiovascular disease (CVD) remains the leading cause of death in Europe, responsible for 1.8 million deaths annually (37% of all EU deaths) and costing 282 billion per year. Despite progress, CVD continues to drive premature mortality and inequality across Member States. The upcoming EU Cardiovascular Health Plan must put prevention at the core.
Policy Priorities for the EU Cardiovascular Health Plan: 1. Put prevention first Address the main risk factors (tobacco, alcohol, diet, sugar, inactivity, stress, air pollution) with cross-sectoral policies. 2. Science-based regulation & harm reduction Recognize that less harmful products can serve as alternative solutions to prevent harm and disease among individuals who are unable to abstain or change their…
The upcoming European Cardiovascular Health Plan needs to take a strong preventative approach to be successful, addressing the root causes of cardiovascular diseases. Cardiovascular diseases remain Europes leading killer, and we cannot rely on medical treatment alone to address this crisis.
Despite clear progress in prevention, diagnosis, and treatment over recent decades, cardiovascular disease (CVD) remains one of the leading causes of mortality and morbidity in Europe. In fact, CVD is responsible for approximately 1.8 million deaths annually across the EUaccounting for nearly 37% of all deaths, according to the European Heart Network.
The Role of Science-based Harm Reduction Policies in Cardiovascular Harm Reduction The Tobacco-Cardiovascular Crisis Cardiovascular disease is influenced by multiple lifestyle factors, including alcohol use, poor diet, smoking, and lack of exercise.
Around 80% of premature deaths from cardiovascular disease (CVD) could be avoided. The EU Action Plan on Cardiovascular Health must therefore focus on one of the most widespread yet preventable risk factors: unhealthy diets. Diet-related risks are a major driver of CVD across Europe, accounting for nearly half of all years of life lost to early death and disability.
ALBUMINURIA FOR EARLY CARDIOVASCULAR RISK DETECTION The European Kidney Health Alliance (EKHA), representing 100 million Europeans with kidney disease, calls for the systematic testing of urinary albumin (albuminuria) as a simple, non-invasive, cost-effective, and evidence-based method to detect major cardiovascular risk, particularly undiagnosed diabetes, hypertension, dyslipidemia and chronic kidney disease (CKD).
We need better ways to bring existing SME innovative solutions into clinical practice. Small companies - such as Detalo Health - lack a clear pathway both nationally and within the Union to bring innovative technologies to the market.
As the main medical and technical leaders of an ongoing Horizon Europe funded STRATIFYHF project, which aims to develop and validate AI-based tools for the diagnosing of heart failure, we would like to express our strong support for the EU Cardiovascular Health Plan. Innovative prevention, screening, diagnostic, management, and rehabilitation strategies for CVD are urgently needed.
I am representing SAMS association, a Spanish association with patients and families living with cardiomyopathies and channelopathies, inherited heart diseases that affect approximately 1 of 300 people in Europe and which first sign is often a sudden death.
I fully support THR programme considering that tobacco consumption is extremely harmful for health in general from cardiovascular diseases to COPD and many types of cancers . Besides It poses a severe life threatening perspective ,an impairment in quality of life and a great burden in health budgets all over the World . For all these reasons quitting tobacco is urgent .
The Dutch Hart Foundation supports the creation of an EU Cardiovascular Health Plan. Cardiovascular diseases are the second cause of death in the Netherlands and the main reason for hospitalisation. The Netherlands has 1.7 million people with cardiovascular disease. If we do nothing, there are almost 1 million more in a few years.
Filed in Dutch · English published by the European Commission
Harteraad, the Dutch patient organization for people with cardiovascular diseases and their relatives, strongly supports the European Commissions initiative to develop an EU Cardiovascular Health Plan. We particularly welcome the recognition of health inequalities, including those affecting women.
Cardiovascular disease is Europes leading killer and a major social and economic burden. Over 60 million people across Europe live with CVD, which causes more than 1 in 3 deaths in the EU many premature and preventable. The economic cost is estimated at 282 billion annually through healthcare, lost productivity and informal care.
The Bulgarian Association for Health and Fitness (BAHF) welcomes the initiative of the European Commission to develop an EU Cardiovascular Health Plan. Cardiovascular diseases are a leading cause of mortality across Europe, and we believe that physical activity must be recognised as a central pillar of prevention and management.
BEUC, the European Consumer Organisation, thanks the Commission for the opportunity to provide feedback to this call for evidence. We welcome the Commissions initiative to tackle cardiovascular diseases (CVDs), the leading cause of death in the European Union, through prevention measures, early detection and treatment, as well as innovation.
IOGT-NTO welcomes the European Commissions initiative to establish an EU Cardiovascular Health Plan. Cardiovascular diseases (CVDs) remain the leading cause of death in Europe, and a strong, coordinated response at the EU level is both timely and necessary. Alcohol is a major - but often overlooked - risk factor for cardiovascular disease.
I do completely support this initiative and implementation of the EU Cardiovascular plan. Taking the 3 pillars of activities under the Plan it worth to develop the roadmap with each specific action. Please, consider more comprehensive approach to management of diseases/medical conditions, for example stroke management should include patient support after stroke. rehabilitation as well as secondary prevention.
While we generally welcome the current plans for an EU Cardiovascular Health Plan, we would find a more general approach towards NCDs more effective. Most NCDs share the same risk factors, but this is not only a question of individual lifestyles, since choices are not made in a vacuum. They are strongly shaped by commercial determinants of health, and by other socioeconomic health determinants.
CALL FOR ACTION: Integrating comprehensive screening for cardio-renal-metabolic diseases into the EU Cardiovascular Health Action Plan Cardiovascular disease (CVD) remains the leading cause of mortality in the European Union, accounting for 32% death.
Key elements for improving cardiovascular health in Europe: — promote the cooperation of European stakeholders to develop resilient solutions: I am thinking in particular of the Startup ecosystem and investors in cardiovascular health – financing startups upstream of CE marking and marketing, to enable disruptive solutions to emerge – to promote and subsidise the purchase of defibrillators, by promoting European…
Filed in French · English published by the European Commission
Healthy habits to prevent cardiovascular disease should be taught at school and basic life support should be taught, such as the European Resuscitacion Council’s Kids Save Lives programme. Publicly accessible programmes for defibrillation (both in public places and on the public highway) would allow early defibrillation of patients suffering from heart stopping and thus improve prognosis.
Filed in Spanish · English published by the European Commission
I AM DR.M.VIJAYA DURGA AN ORTHOPEDIC RESIDENT. NOW I AM DOING FELLOWSHIP IN OBGY WITH LOTS OF PASSION. I HAVE SEEN LOTS OF PATIENTS DIED DURING RESUSCITATION. MOST OF THE PATIENT ARE MIDDLE AGE WITH CARDIAC COMORBIDITIES. WITH WHATEVER THE REASON THEY ARE ADMITTED IN THE HOSPITAL. THE ULTIMATE REASON FOR DEATH CARDIOPULMONARY FAILURE. I HAVE SEEN 9 PATIENTS DIED INFRONT OF ME DURING RESUSCITATION.
Cardiovascular diseases represent one of the greatest burdens on public health systems in the EU, and we therefore appreciate that this topic is gaining the attention of the Commission. As an association advocating for users of alternative tobacco products that help them quit smoking traditional cigarettes, we would like to highlight the potential risks we perceive in the plan. 1.
The EU cardiovascular health plan represents a critical opportunity to transform cardiovascular care across Europe by leveraging emerging digital health technologies and evidence-based approaches. Recent advances in telemedicine and remote monitoring have demonstrated the significant potential for digital platforms to address the three key action areas outlined in the plan.
I would like to highlight the potential role of photobiomodulation (PBM) as an emerging, non-invasive approach to improving cardiovascular health and prevention. PBM uses specific wavelengths of light, usually in the red to near-infrared spectrum, to stimulate beneficial cellular and molecular processes.
As a medical doctor and researcher in internal medicine with a strong focus on cardiovascular prevention, I find this initiative highly relevant and timely. Cardiovascular diseases remain a leading cause of morbidity and mortality in Europe, and coordinated EU action is essential to reduce their burden.
As a professionally trained whole food plant-based cook with solid nutritional knowledge my feedback focusses on the enormous impact of food on cardiovascular health. As cardiovascular diseases remain the leading cause of death and disability in Europe, costing the EU an estimated 282 billion annually, the EU cardiovascular health plan can be a pivotal in igniting a grassroots approach that will benefit EU citizens…
It is very good initiative - to look more in prevention, not only in treatment of diseases. In my opinion, it will be important at the stage of evaluating risk factors, to take into account the working conditions of groups of people, working in high temperature working environment, with high levels of noise (nevertheless that these levels would be below the exposure limits), also with sources of radiofrequency…
Cardiovascular diseases (CVDs) remain the leading cause of mortality and disability in the European Union, with enormous health and economic consequences. To be effective, the forthcoming EU Cardiovascular Health Plan should explicitly include type 2 diabetes (T2D).
Cardiovascular diseases (CVDs) remain the leading cause of death and disability in Europe, costing the EU an estimated 282 billion annually.1 CVDs are interconnected with other often preventable - major non-communicable diseases (NCDs) such as diabetes, obesity, lipid conditions, and chronic respiratory disease, sharing common risk factors and social, environmental, and commercial determinants.
1. Holistic and Coordinated Care Integration of health and social care ensures that patients receive not only medical treat-ment but also support for social determinants of health (e.g., nutrition, housing, mental health). By connecting hospitals, primary care, social workers, and community organisations, care becomes seamless, reducing fragmentation and improving long-term health outcomes. 2.
As Chair of the European Resuscitation Council and an expert in cardiac arrest, I strongly welcome the ambition of the EU Cardiovascular Health Plan. Cardiovascular diseases remain Europes leading cause of death, and cardiac arrest represents their most devastating and time-sensitive manifestation.
The EU cardiovascular health plan will focus on actions that bring tangible benefits to people, governments and stakeholders across the EU. The plan aims to strengthen the EU’s economic resilience by: improving the health of millions of citizens through prevention, early diagnosis and access to treatment by enhancing innovation by strengthening market capacities and competitiveness not only of the EU health industry…
Filed in Italian · English published by the European Commission
The Cardiovascular Health plan has completely overlooked the critical kidney-heart connection. A decrease in eGFR is closely linked to a higher likelihood of cardiovascular events and mortality from cardiovascular causes. Additionally, the presence of albumin in the urine is a recognized risk factor for cardiovascular disease.
Stroke is a major cause of death and disability in Cyprus and across the EU. In Cyprus, there are more than 2000 new stroke cases annually. One-third of these patients die, one-third live with long-term disability, and only one-third recover fully. Alarmingly, one-third of strokes occur in people under the age of 65.
Filed in Greek · English published by the European Commission
The environmental determinants of CVD, including but not limited to chemical exposures, air pollution, and climate change are absolutely vital to understanding the risks, management, and mitigation of these diseases including improving their outcomes. https://academic.oup.com/cardiovascres/article/118/14/2880/6381568 This has to be a central theme to this initiative.
Recreational Adapted Sports Our Journey and Impact Over the course of our work with recreational adapted sports, we have experienced what can be described as moderate yet meaningful success, particularly through three key activities: walking football, walking basketball, and catchball.
Opinion on the EU Plan for Health Heart & Circular Aspects of Low-Intensity Vibration (Marodyne LIV) In the context of the EU approach to the prevention of cardiovascular diseases, we see the Low-Intensity Vibration (LIV) with Marodyne LIV as a promising complementary measure with the following findings: 1.
Filed in German · English published by the European Commission
Method. Every quote is verbatim from the organization’s own submission to the European Commission, trimmed to its opening passage and never summarized by a model. Where a submission was filed in another EU language we show the English text the European Commission publishes alongside it, labeled on the quote; the original is one click away at the source. Groupings use the respondent type the organization itself selected when filing. We deliberately do not label anyone “supportive” or “opposed”. You read what they wrote and draw your own conclusion. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.
